318 related articles for article (PubMed ID: 33440212)
21. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
Cockwell P; Cook M
Adv Chronic Kidney Dis; 2012 Sep; 19(5):324-32. PubMed ID: 22920643
[TBL] [Abstract][Full Text] [Related]
22. Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report.
Donati G; Zappulo F; Croci Chiocchini AL; Comai G; Zamagni E; La Manna G
Hemodial Int; 2019 Jul; 23(3):E97-E99. PubMed ID: 30791209
[TBL] [Abstract][Full Text] [Related]
23. Rapid reduction of extremely high kappa free light chains in a patient with myeloma cast nephropathy.
Snozek CLH; Kinard TN; Adamski J
J Clin Apher; 2018 Jun; 33(3):439-443. PubMed ID: 29427353
[TBL] [Abstract][Full Text] [Related]
24. Multiple myeloma with acute light chain cast nephropathy.
Leung N; Rajkumar SV
Blood Cancer J; 2023 Mar; 13(1):46. PubMed ID: 36990996
[TBL] [Abstract][Full Text] [Related]
25. Treatment of acute kidney injury with cast nephropathy.
Walther C; Podoll AS; Finkel KW
Clin Nephrol; 2014 Jul; 82(1):1-6. PubMed ID: 24725380
[TBL] [Abstract][Full Text] [Related]
26. Renal failure in multiple myeloma and its treatment.
Ryšavá R
Vnitr Lek; 2020; 66(7):425-431. PubMed ID: 33380121
[TBL] [Abstract][Full Text] [Related]
27. [New insights in the treatment of myeloma with renal failure].
Moumas E; Hanf W; Desport E; Abraham J; Delbès S; Debiais C; Lacotte-Thierry L; Touchard G; Jaccard A; Fermand JP; Bridoux F
Nephrol Ther; 2011 Nov; 7(6):457-66. PubMed ID: 21515102
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
Hutchison CA; Heyne N; Airia P; Schindler R; Zickler D; Cook M; Cockwell P; Grima D
Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
[TBL] [Abstract][Full Text] [Related]
29. Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy.
Bridoux F; Arnulf B; Karlin L; Blin N; Rabot N; Macro M; Audard V; Belhadj K; Pegourie B; Gobert P; Cornec Le Gall E; Joly B; Karras A; Jaccard A; Augeul-Meunier K; Manier S; Royer B; Caillot D; Tiab M; Delbes S; Suarez F; Vigneau C; Caillard S; Arakelyan-Laboure N; Roos-Weil D; Chevret S; Fermand JP;
J Clin Oncol; 2020 Aug; 38(23):2647-2657. PubMed ID: 32574117
[TBL] [Abstract][Full Text] [Related]
30. Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.
Manohar S; Nasr SH; Leung N
Curr Hematol Malig Rep; 2018 Jun; 13(3):220-226. PubMed ID: 29725932
[TBL] [Abstract][Full Text] [Related]
31. Recovery of kidney function following delayed use of Theralite™ dialyzer in a patient with myeloma cast nephropathy.
Dahal K; Shastri S; Narayanasami U; Bijol V; Rider K; Strom JA; Jaber BL
Clin Nephrol; 2013 Apr; 79(4):318-22. PubMed ID: 22541683
[TBL] [Abstract][Full Text] [Related]
32. A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study.
Lin ZS; Qin AB; Wang SX; Yu XJ; Dong B; Xiong ZY; Chen MH; Zhou FD; Zhao MH
J Nephrol; 2021 Aug; 34(4):1169-1177. PubMed ID: 33394345
[TBL] [Abstract][Full Text] [Related]
33. [Management of Cast Nephropathy].
De Simone E; Fenoglio R; Cortazzi S; Careddu A; Geraci G; Bugliosi F; Sciascia S; Roccatello D
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007838
[TBL] [Abstract][Full Text] [Related]
34. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma.
Hutchison CA; Batuman V; Behrens J; Bridoux F; Sirac C; Dispenzieri A; Herrera GA; Lachmann H; Sanders PW;
Nat Rev Nephrol; 2011 Nov; 8(1):43-51. PubMed ID: 22045243
[TBL] [Abstract][Full Text] [Related]
35. Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy.
Mehta S; Shtaynberg N; Goldman M; Asti D; Kiroycheva M; Pepe J
Hematology; 2012 Jul; 17(4):229-31. PubMed ID: 22889516
[TBL] [Abstract][Full Text] [Related]
36. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.
Hutchison CA; Bradwell AR; Cook M; Basnayake K; Basu S; Harding S; Hattersley J; Evans ND; Chappel MJ; Sampson P; Foggensteiner L; Adu D; Cockwell P
Clin J Am Soc Nephrol; 2009 Apr; 4(4):745-54. PubMed ID: 19339414
[TBL] [Abstract][Full Text] [Related]
37. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy.
Matthai SM; Alexander S; Jacob S; Duhli N; David VG; Varughese S
Indian J Pathol Microbiol; 2020; 63(3):463-466. PubMed ID: 32769341
[TBL] [Abstract][Full Text] [Related]
38. Prolonged hemodialysis for acute kidney injury in myeloma patients.
Hanf W; Guillaume C; Jolivot A; Chapuis-Cellier C; Guebre-Egziabher F; Fontana A; Fouque D; Juillard L
Clin Nephrol; 2010 Oct; 74(4):319-22. PubMed ID: 20875387
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study.
Royal V; Leung N; Troyanov S; Nasr SH; Écotière L; LeBlanc R; Adam BA; Angioi A; Alexander MP; Asunis AM; Barreca A; Bianco P; Cohen C; Drosou ME; Fatima H; Fenoglio R; Gougeon F; Goujon JM; Herrera GA; Knebelmann B; Lepori N; Maletta F; Manso R; Motwani SS; Pani A; Rabant M; Rennke HG; Rocatello D; Rosenblum F; Sanders PW; Santos A; Soto K; Sis B; Touchard G; Venner CP; Bridoux F
Blood; 2020 May; 135(21):1833-1846. PubMed ID: 32160635
[TBL] [Abstract][Full Text] [Related]
40. Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.
Hada R; Poudyal B; Sharma A; Khatri R
JNMA J Nepal Med Assoc; 2012; 52(188):192-5. PubMed ID: 23591252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
